ABSTRACT
Background Scabies outbreaks were common in formal and informal refugee/migrant camps across Europe in 2014-17. This qualitative study aimed to provide insight into the experiences and perspectives of healthcare staff who treated scabies or managed outbreaks in these camps.
Methods Recruitment was primarily through online networks of healthcare staff involved in medical care in refugee/migrant settings. Retrospective semi-structured telephone interviews were conducted, transcribed, and qualitative framework analysis carried out.
Results Twelve participants who had worked in camps across seven European countries were interviewed. They reported that in the camps they had worked scabies diagnosis was primarily clinical, and without dermatoscopy, and treatment and outbreak management varied highly. Seven participants stated scabicide treatment was provided in camps whilst they were there, the remaining five reported only symptomatic management was offered. They described the camps as difficult places to work, with poor standards of living experienced by residents. Key perceived barriers to scabies control were (i) lack of Water, Sanitation and Hygiene facilities, specifically: absent/ limited showers (difficult to wash off irritant topical scabicides); inability to wash clothes and bedding (may have increased transmission/re-infestation), (ii) social factors: language; stigma; treatment non-compliance; mobility (interfering with contact tracing and follow-up treatments), (iii) healthcare factors: scabicide shortages and diversity; lack of examination privacy; staff inexperience, (iv) organisational factors: overcrowding; ineffective inter-organisational coordination; lack of support and maltreatment by state authorities (e.g. not providing basic facilities, and obstruction of self-care by camp residents and of aid efforts by NGOs).
Conclusions We recommend development of accessible scabies guidelines for camps, use of consensus diagnostic criteria, and oral ivermectin mass treatments. In addition, as much of the work described was by small, volunteer staffed NGOs, we should reflect how we in the wider healthcare community can better support such initiatives, and those they serve.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was financially supported by Brighton and Sussex Medical School from internal funds and did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Brighton and Sussex Medical School Research Governance and Ethics Committee approved the research (ER/BSMS3398/1).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Relevant qualitative data is included in the article and Appendix, along with summarised quantitative data. Machine readable study data will be available on publication at: https://sussex.figshare.com/
